TABLE 1

Individual Patient Characteristics

Patient no.	Sex	Mutation	Age (d)	Age (s)	Location of primary tumor	Hypersecretion
1	F	HIF2A	38	40	R perirenal	NE, MTT, CgA
2	F	HIF2A	18	24	R adrenal	DA, MTT
3	F	HIF2A	14	33	L paraaortic	NE, NMN, CgA
4	F	HIF2A	36	46	R paraaortic	Negative
5	F	No mutation found	57	57	L paracaval	NMN, CgA
6	F	No mutation found	39	39	R adrenal	NMN, NE, MN, MTT, CgA
7	M	No mutation found	27	36	L adrenal	NE, NMN, DA, CgA
8	M	No mutation found	18	45	L adrenal	NE, NMN, DA, CgA
9	F	PHD1	25	50	R paraadrenal	NE, NMN, MN, MTT, CgA
10	M	HIF2A	15	17	L adrenal	NE, NMN, CgA, DA
11	F	No mutation found	30	30	R adrenal	NE, NMN, MTT, CgA
12	F	HIF2A	8	11	R paraaortic	NE, NMN, MN, MTT, CgA
13	F	PHD2	42	63	L adrenal	NE, NMN, CgA
14	M	No mutation found	16	27	L thoracic paraspinal	NE, DA, CgA

Age (d) = age at diagnosis; Age (s) = age at study; NE = norepinephrine; MTT = methoxytyramine; CgA = chromogranin A; DA = dopamine; NMN = normetanephrine; MN = metanephrine.